Irwin, Rebecca M.
Thomas, Matthew A.
Fahey, Megan J.
Mayán, María D.
Smyth, James W.
Delco, Michelle L. https://orcid.org/0000-0003-0973-2075
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08AR068470)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R03AR075929)
Cornell University (Cornell University)
Harry M. Zweig Memorial Fund for Equine Research (Harry M. Zweig Memorial Fund for Equine Research)
Orthopaedic Research Society (Orthopaedic Research Society)
Article History
Received: 3 May 2024
Accepted: 9 September 2024
First Online: 10 October 2024
Declarations
:
: This manuscript includes the use of an immortalized human chondrocyte line and human MSCs that are commercially available. The creation of the immortalized chondrocyte cell line has been previously published [ ], and initial ethical approval and informed consent was obtained for the RoosterBio human MSCs. The Delco lab was granted institutional approval to work with human and animal cells and tissues on 10/11/2022 by the Cornell University Institutional Biosafety Committee (Title: The study of mitochondria in orthopedic disease; MUA Approval Number: 16342-2).
: Not applicable.
: The authors declare that they have no competing interests.